Revvity Stock Forecast & Price Target
Revvity Price Target 2026
The Quantum Forecast sees a price target of $154.89 (−3.8%) for Revvity in about one month (by Dec 10, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $161.04. Click to see the forecast in the chart.
Revvity Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees Revvity at $160.63 (−0.25%) today around 10:45 AM ET and at $161.46 (+0.26%) tomorrow around 2 AM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
Revvity Stock 2026: Price Performance
Revvity stock has gained 66.4% since the start of 2026 and currently trades at $161.04 (as of Nov 11, 2026). Over the same period the S&P 500 is up 10.9%, putting the stock 55.5 percentage points ahead of the index. Over the past 52 weeks the price ranged between $81.14 and $171.54; it is currently 6.1% below its high of Nov 3, 2026.
Revvity Forecast 2027
Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $150.70 for Revvity – −6.4% from today. The range band runs from $83.07 – $218.32: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for Revvity
There are no user forecasts for Revvity yet – be the first to make one.
Make your own forecastAbout Revvity
Revvity, known as PerkinElmer until 2023, provides tools for life sciences research and diagnostics. Based in Waltham, Massachusetts, the company sells reagents, antibodies, lab instruments and software for drug discovery, including products from its acquisition BioLegend. In diagnostics, Revvity is strong in newborn screening, which detects metabolic and genetic disorders early, as well as in reproductive health testing. Its German subsidiary Euroimmun, based in Lübeck, develops tests for autoimmune diseases, allergies and infections. With the name change, the company separated from its traditional analytical instruments business, which kept the PerkinElmer name; its history dates back to 1937.
Customers include pharmaceutical and biotech companies, universities, research institutes, clinical labs, hospitals and government screening programs in many countries. A large share of revenue comes from consumables, software and services, which tend to recur. Biotech funding, pharma research budgets and diagnostics demand in China are relevant factors for the business. The ticker symbol is RVTY (NYSE), and the stock belongs to the S&P 500.
The current price of Revvity stock is $161.04 (+0.70% vs. the previous close). In today's trading the high was $161.04 and the low $157.64.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about Revvity Stock
What is the Revvity stock forecast?
The Quantum Forecast expects Revvity to reach $154.89 in about one month (by Dec 10, 2026), a change of −3.8% from the current price of $161.04. Over roughly 10 months (by Sep 2027) the price target is $150.70 (−6.4%).
What is the Revvity stock price target?
Quantum Forecast price targets by time frame: 1 month $154.89 (−3.8%), 2 months $169.73 (+5.4%), 6 months $168.02 (+4.3%), 10 months $150.70 (−6.4%). The range band shows the typical fluctuation around these targets.
Will Revvity stock go up or down?
In the short term the Quantum Forecast points down (−3.8% over one month). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for Revvity?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.